![](/img/cover-not-exists.png)
Phase I clinical trial to determine maximum tolerated dose of oral albendazole in patients with advanced cancer
Mohammad H. Pourgholami, Michael Szwajcer, Melvin Chin, Winston Liauw, Jonathan Seef, Peter Galettis, David L. Morris, Matthew LinksVolume:
65
Language:
english
Pages:
9
DOI:
10.1007/s00280-009-1157-8
Date:
February, 2010
File:
PDF, 341 KB
english, 2010